The global rise in the prevalence and incidence of diabetes, continuous technological advancement, increasing demand for less invasive products and increase in R&D investments are driving the growth of glucose monitoring market. ...
-
How fast the market of your interest is growing?
Key drivers behind the growth..
-
What are your biggest Challenges?Identify the key problems.. -
What are your Revenue pockets?Areas you need to bet.. -
What are your Competitors doing?Know your competitive edge.. -
Who is your Customer?Get Their changing preferences..
Intelligence Quotient for Innovation Research and Consultancy
IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.
We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.
what we offer
Report Store
Healthcare is an ever changing domain with an explosion in knowledge and breakthrough discoveries. Hence, it has become a major thrust area for the global giants in the pharmaceutical, biotechnology and medical devices industries and also for corporates involved in research and development of new products.
IQ4I's focus areas in Healthcare include Pharmaceuticals, biotechnology, Medical devices and Healthcare IT. Since these domains cater to humans, they are subject to stringent regulatory mechanisms requiring highly specialized skills in knowledge processing, with superior quality and adherence to global standards.
IQ4I
Latest Reports
Glucose Monitoring consist of products that are essential for patients suffering diabetes. With the projected rise in aged population and awareness about such conditions, the market is focused on growing with newer technology and improved products.
The demand for cost effective alternatives for animal testing and increasing approval of biologics and biosimilars is driving the growth of cell-based assays global market.
Active Pharmaceutical Ingredients (API) Global Market estimated to be worth $307.2 billion by 2025. API market is segmented by synthesis including synthetic chemicals, HPAPI and biotech API.
Small molecules continue to dominate the global therapeutics market, many molecules going off-patent is paving way for introduction of generics creating a favorable opportunity for the Pharmaceutical contract manufacturers.
Increasing demand for minimally invasive surgical procedure leading fast recovery and reduced hospital stays, technological innovations offering a wider scope of applications for endoscopy, the rise in obese population preferring bariatric surgery for weight reduction are the factors driving the market growth.
Cell lines are one of the major tools in pharmaceutical research and have wide range of applications in gene function studies, drug discovery assays, the production of biotherapeutics and diagnostics.
Many large and small pharmaceutical companies are turning to outsourcing the drug manufacture process to reduce capital investments on capacities and focus more on their core competencies.
This report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery, preclinical development, clinical phases and commercial manufacturing of biologics.
The report covers all the drugs that are in various phases of development (Discovery, Preclinical and Clinical).
Pain is a debilitating condition, which arise due to various reasons which is not completely curable, but can be treated with pain management devices and surgery. Increase in the prevalence of chronic diseases and pain disorders, rise in aging population, and adverse effects of opioids, are driving the market.
IQ4I
Latest News
Factors driving the Cell-Based Assays market are rising use of the cell-based assay in drug discovery and development, increasing focus on biologics, and technological advancements....
IQ4I
Clientele
Offering solutions to >500 clients from the U.S., Europe, Japan, Korea, Singapore and Australia in realizing the market potential and competitive intelligence across healthcare domains (Medical Technologies, Pharmaceutical, Biotech and Life Sciences).
